SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is trending as the community rallies around its status as a leading cat-themed meme coin on the Base network, fueling speculation about potential exchange listings and future price breakouts. Investors are actively debating the timing of a rally while comparing current consolidation to previous bullish cycles.

StupidCoin

The StupidCoin community is actively debating the project's legitimacy amidst claims of copycat tokens while sentiment remains bullish on recent chart patterns and potential viral growth. Supporters are framing the asset as a long-term hold, often drawing comparisons to other viral meme coins within the broader Solana ecosystem.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following a positive pre-BLA meeting with the FDA, which confirmed the acceptability of clinical trial data and cleared a path for a potential BLA submission later in 2026. The community is actively discussing the durability and best-in-class potential of their lead candidate, sonelokimab, while debating the significance of upcoming 52-week clinical data and potential M&A activity.

Spitcoin is a community-driven cryptocurrency built on the Solana blockchain that powers a decentralized creator economy through the LimitlessFlo platform.  The project focuses on giving creators full control over their content and earnings by enabling instant monetization from day one—through tips, subscriptions, live streaming, and marketplace transactions—without the restrictions of traditional platforms like bans, algorithm suppression, or delayed payouts.  At its core, Spitcoin is about combining meme culture with real utility, creating a self-sustaining ecosystem where platform activity drives token demand, and token usage fuels platform growth.

SpitCoin

SpitCoin is gaining traction as investors highlight its role in the LimitlessFlo ecosystem, with community members actively discussing its strategic partnerships and potential synergy with other trending crypto assets. The project is drawing attention as market participants monitor accumulation activity and express optimism regarding its current developmental momentum.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is generating significant discussion as the community tracks its potential for institutional-led growth, with traders highlighting recent network performance and upcoming integrations as key drivers. Investors are actively debating accumulation strategies near current price levels while monitoring technical breakout points to gauge whether the asset can mirror the historical adoption patterns of other major layer-1 platforms.

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

Nurix Therapeutics Inc

Nurix Therapeutics is gaining attention as investors weigh the potential of its targeted protein degradation platform against the challenges of a capital-intensive biotech environment, with the community closely tracking upcoming data readouts and the potential for strategic M&A interest. Supporters emphasize the mechanistic advantages of the company's degrader pipeline, while skeptics remain focused on cash burn and the long-term need for additional funding.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's is currently trending as investors weigh significant concerns over weak quarterly revenue and earnings against the potential for a short squeeze, given the stock's elevated short interest. Community discussion is polarized, with bulls pointing to new management initiatives and potential buyout interest while bears highlight declining foot traffic and broader consumer spending headwinds.

Rewarding holding and rejecting the culture of fast flips. Longterm sustainability by using a multi-phase dynamic rewards system. Meme that inspires creativity and innovation. Fun community involvement, including games, memes, and also serious holder mindset. We have automated rewards to holders, buyback and burns and are giving back to ocean cleanup initiatives. All pump fun creator rewards are used for the buyback and burn of the token, rewarding holders, and donating to nonprofits that clean our oceans.

MAKE HOLDING GREAT AGAIN

MHGA is trending as the community highlights its recent milestones, including verification on major exchange aggregators and the ongoing development of its Solana-based reward mechanism for holders. Investors are actively discussing the project's utility and commitment to charity initiatives while expressing strong conviction in the brand's long-term growth narrative.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community rallies around its upcoming one-year anniversary and a significant portion of the supply being locked, fueling sentiment that long-term holders are committed. Investors are highlighting the project's persistent growth and focus on positivity as key drivers for potential upward momentum.

Ethena

Ethena (ENA) is trending as investors monitor its integration into high-profile fintech infrastructure and stablecoin-focused treasury strategies, alongside speculation regarding its role in major institutional DeFi partnerships. While some community members are focused on price volatility and technical chart patterns, others remain engaged in deep-dive discussions about the project's long-term utility, upcoming unlocks, and potential for expanded adoption across the digital asset ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Liminatus Pharma, Inc. hit a record high on Wednesday after the company declared it had restored compliance with Nasdaq listing standards.The stock closed at $12.71, up 132.8% on Wednesday, with after-hours trading pushing the price further up 69.2% to $21.50.Liminatus received formal confirmation from Nasdaq on June 3, confirming the Nasdaq Listing Rule 5250(c)(1), which requires timely submission of reports to the U.S. Securities and Exchange Commission (SEC).&nbsp;The matter is now considered closed.Earlier on May 29, the company received a notice for not submitting its quarterly report on Form 10-Q for the quarter ended March 31, 2025, promptly.&nbsp;Liminatus submitted the delayed report on June 2, reinstating its SEC reporting compliance.Liminatus came public in early May following a Special Purpose Acquisition Company (SPAC) merger.On Stocktwits, retail sentiment was ‘extremely bullish’ amid ‘extremely high’ message volume.While pointing out that the Liminatus Pharma stock held support, one user said they expected the rally to continue to the next day due to the relatively small float size of 150,000.<stembedurl>https://stocktwits.com/WealthQuest/message/616859995</stembedurl>Another user suggested that the company was preparing to spike to $35.<stembedurl>https://stocktwits.com/View2021/message/616842522</stembedurl>Since its May listing, the stock&nbsp;has risen 9.7% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Generic capsules, 25 July 2004. AFR Picture by LOUIE DOUVIS (Photo by Fairfax Media via Getty Images)

Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance 

The company had previously faced a notice for delayed filings but has since rectified the issue.

Equity

Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.

Liminatus Pharma Inc. - Ordinary Shares - Class A

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

Current Price	$0.2028
Prev Close	$0.2005
Open	$0.2047
Dividend Yield	0.00%
50-Day Moving Average	$0.2095
Beta	1.07
Avg. Volume	8.02M
PE Ratio	-0.56

52-Week High	$33.66
52-Week Low	$0.1592
Market Capitalization	$9.1M
EPS (Annual)	-$0.4297
Price to Book	-0.56
Revenue Per Employee	$0.00

LIMN
Liminatus Pharma Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest LIMN News

LIMNLiminatus Pharma Inc.